Results 31 to 40 of about 12,929 (204)

Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression

Cancer Cell International, 2021
Background Bladder cancer (BLCA) is the most common genitourinary tumor but lacks specific diagnostic biomarkers. Recent years have witnessed significant advances in the use and approval of immune checkpoint blockade (ICB) therapy to manage BLCA at ...
YiHeng Du, Jin Cao, Xiang Jiang, XiaoWei Cai, Bo Wang, Yi Wang, XiZhi Wang, BoXin Xue   +7 more
doaj   +1 more source

Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer

Frontiers in Immunology, 2023
RationaleRNA modifications, containing m6A, m1A, alternative polyadenylation and adenosine-to-inosine RNA editing, involve in critical cancerous immunity and cancerous processes. However, the functional roles of RNA modification writers in bladder cancer
Yao Zhang, Ying Chen, Wen Wen
doaj   +1 more source

RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming

Journal of Cellular and Molecular Medicine, 2023
AbstractRecently, epigenetics showed essential roles in tumour microenvironment (TME) and immunotherapy response, however, the functions of RNA 5‐methylcytosine (m5C) modification in TME remains unknown. According to 13 m5C regulators, we evaluated 412 BLCA patients from The Cancer Genome Atlas (TCGA) database.
Dali Yan, Yongsong Xie, Liyuan Huang, Yi Zhang, Runhuan Gu, Huaibing Xie, Xing Huang, Hao Luo   +7 more
openaire   +2 more sources

Table1_AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma.DOCX [PDF]

, 2022
A large proportion of bladder cancer (BLCA) patients suffer from malignant progression to life-threatening muscle-invasive bladder cancer (MIBC). Inflammation is a critical event in cancer development, but little is known about the role of inflammation ...
Lingli Zhou (539752), Houhong Zhou (10718112), Lei Zhang (38117), Huaishan Hong (11248509), Weihan Luo (12186878), Dongdong Tang (4521793), Yuqing Li (28192), Dewang Zhou (12186881)   +7 more
core   +1 more source

Additional file 3 of TRIM38 triggers the ubiquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer [PDF]

, 2021
Additional file 3: Table S3.
Ning Zhang (23771), Xin Xie (311744), Wenbin Rui (11838546), Xiaojing Wang (147040), Yu Zhu (250261), Hongchao He (3864172)   +5 more
core   +1 more source

Preoperative White Blood Cell-Related Indicators Can Predict the Prognosis of Patients with Transurethral Resection of Bladder Cancer

Journal of Inflammation Research, 2022
Mingde Gao1 *, Qiuxing Yang2 *, Haifei Xu,1 Zhigang Chen,1 Xiaolin Wang,1 Haifeng Guo1 1Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of China; 2Department of ...
Gao M, Yang Q, Xu H, Chen Z, Wang X, Guo H   +5 more
doaj  

Additional file 8 of Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment [PDF]

, 2022
Additional file 8: Figure S3. KRT6B enhanced the proliferation of BLCA cells. A Colony formation assay indicated that KRT6B could enhance the proliferation of BLCA cells.
Qiang Song (472518), Jie Han (128758), Qiang Lv (123647), Xiao Yang (19898), Juntao Zhuang (12070760), Hao Yu (157186), Haiwei Yang (517869), Yidong Cheng (560022), Kai Li (205203)   +8 more
core   +1 more source

Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms

BMC Cancer, 2019
Background The prognosis of bladder urothelial carcinoma (BLCA) varies greatly among patients, and conventional pathological predictors are generally inadequate and often inaccurate to predict the heterogeneous behavior of BLCA.
Shuxiong Zeng, Anwei Liu, Lihe Dai, Xiaowen Yu, Zhensheng Zhang, Qiao Xiong, Jun Yang, Fei Liu, Jinshan Xu, Yongping Xue, Yinghao Sun, Chuanliang Xu   +11 more
doaj   +1 more source

Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer

Metabolites, 2022
Bladder Cancer (BLCA) is the ninth most frequently diagnosed cancer globally and the sixth most common cancer in the US. African Americans (AA) exhibit half the BLCA incidence compared to European Americans (EA), but they have a 70% higher risk of cancer-
Karthik Reddy Kami Reddy, Danthasinghe Waduge Badrajee Piyarathna, Abu Hena Mostafa Kamal, Vasanta Putluri, Shiva Shankar Ravi, Roni J. Bollag, Martha K. Terris, Yair Lotan, Nagireddy Putluri   +8 more
doaj   +1 more source

Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling

Frontiers in Cell and Developmental Biology, 2022
Bladder cancer (BLCA) is a tumor that possesses significant heterogeneity, and the tumor microenvironment (TME) plays an important role in the development of BLCA.
YiHeng Du, YiHeng Du, YiQun Sui, Jin Cao, Xiang Jiang, Yi Wang, Jiang Yu, Bo Wang, XiZhi Wang, BoXin Xue   +9 more
doaj   +1 more source